Last reviewed · How we verify

NCT05905419: OPAL

Neuroimaging of Opioid Phase (OPAL)

Recruiting now NA Last updated 4 September 2025
What this trial tests

NA trial testing Opioid Phase in Chronic Pain in 140 participants. Currently enrolling.

Timeline
1 June 2023
Primary endpoint
30 June 2027
30 June 2027

Quick facts

Lead sponsorDuke University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment140
Start date1 June 2023
Primary completion30 June 2027
Estimated completion30 June 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Duke University

Who can join

18 and older, female only, with Chronic Pain or Opioid Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare activity in the brains of female adults with chronic pain and/or opioid use, and healthy female adults that may help to develop new and targeted treatments for adults with chronic pain and alternatives to opioid therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Reduced trapezius pressure pain threshold in fibromyalgia and opioid use.
    Lei C, Park SH, Evington EJ, Rosser MA, et al · · 2025 · cited 4× · PMID 40472985 · DOI 10.1016/j.jpain.2025.105455

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Duke University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05905419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing